Collectively, these results demonstrate that engineered OMV‐mediated photoimmunotherapy combined with CD47 nanobodies holds enormous potential to suppress primary and metastatic CDH17‐positive CRC and promote complete tumour eradication. Here, CDH17 is linked to neoplasm.